Evidence map›Paper›PMID 37552759›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Analysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing.

Gage O Leighton, Shengzhe Shang, Sean Hageman, Gordon D Ginder, David C Williams

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  11. Review
  12. Review
  13. Epigenetic insights into Fragile X Syndrome.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gage O LeightonDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.ORCID 0000-0003-4636-0370
Shengzhe ShangMassey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298.ORCID 0000-0002-0919-1208
Sean HagemanDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.
Gordon D GinderMassey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298.ORCID 0000-0001-9875-3198
David C WilliamsDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599.ORCID 0000-0002-6536-4038
University of North Carolina at Chapel Hill · USVirginia Commonwealth University · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kim Felder Rhoads · 1985 to 2026
$51.0M
The Role of the MBD2-NuRD Complex in Gamma-Globin Gene SilencingR01DK115563 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GINDER, GORDON D, WILLIAMS, DAVID COLLIN · 2018 to 2025
$6.3M
Regulation of Globin Gene Expression In Erythroid Differentiation & DevelopmentR56DK029902 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GINDER, GORDON D · 2012 to 2012
$135k
NCI NIH HHS P30 CA016059NCI NIH HHS P30 CA016086NIDDK NIH HHS R01 DK115563NIDDK NIH HHS R56 DK029902
6 · The paper itself

Abstract

The nucleosome remodeling and deacetylase (NuRD) complex modifies nucleosome positioning and chromatin compaction to regulate gene expression. The methyl-CpG-binding domain proteins 2 and 3 (MBD2 and MBD3) play a critical role in complex formation; however, the molecular details of how they interact with other NuRD components have yet to be fully elucidated. We previously showed that an intrinsically disordered region (IDR) of MBD2 is necessary and sufficient to bind to the histone deacetylase core of NuRD. Building on that work, we have measured the inherent structural propensity of the MBD2-IDR using solvent and site-specific paramagnetic relaxation enhancement measurements. We then used the AlphaFold2 machine learning software to generate a model of the complex between MBD2 and the histone deacetylase core of NuRD. This model is remarkably consistent with our previous studies, including the current paramagnetic relaxation enhancement data. The latter suggests that the free MBD2-IDR samples conformations similar to the bound structure. We tested this model of the complex extensively by mutating key contact residues and measuring binding using an intracellular bioluminescent resonance energy transfer assay. Furthermore, we identified protein contacts that, when mutated, disrupted gene silencing by NuRD in a cell model of fetal hemoglobin regulation. Hence, this work provides insights into the formation of NuRD and highlights critical binding pockets that may be targeted to block gene silencing for therapy. Importantly, we show that AlphaFold2 can generate a credible model of a large complex that involves an IDR that folds upon binding.

Indexed as

Histone DeacetylasesNucleosomesChromatinGene SilencingHistone Deacetylase 1Mi-2 Nucleosome Remodeling and Deacetylase ComplexChromatinHistone Deacetylase 1Histone DeacetylasesMi-2 Nucleosome Remodeling and Deacetylase ComplexNucleosomesAlphaFold2chromatin remodelingDNA methylationintrinsically disordered proteinMBD2-NuRD

Identifiers

PMID37552759
PMCPMC10433457
OpenAlexW4385654946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.